BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Access Pharmaceuticals 

2600 Stemmons Freeway
Suite 176
Dallas  Texas  75207   U.S.A.
Phone: 214-905-5100 Fax: 214-905-5101


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Pharmaceuticals





 Company News
Access Pharmaceuticals (ACCP) Provides Update On Development Of LexaGard, A Proprietary Formulation Of Amlexanox 4/9/2014 8:29:54 AM    More...
Access Pharmaceuticals (ACCP) Advances Development Of Proctigard™ For Radiation Proctitis 3/21/2014 10:35:15 AM    More...
Access Pharmaceuticals (ACCP) Announces Publication Of MuGard Clinical Data In Cancer Journal 2/18/2014 9:50:04 AM    More...
Access Pharmaceuticals (ACCP) Announces MuGard Poster Presentation at ASTRO Conference 9/24/2013 9:01:30 AM    More...
Access Pharmaceuticals (ACCP) Awarded Second European Patent for MuGard 9/12/2013 9:45:50 AM    More...
Access Pharmaceuticals (ACCP) to Host Investor Call on Wednesday, July 31, 2013 7/26/2013 9:45:35 AM    More...
Access Pharmaceuticals (ACCP) Announces Positive Top-Line Data From MuGard™ Phase IV Clinical Trial In Oral Mucositis Patients Presented At MASCC/ISOO 2013 Symposium 6/27/2013 4:51:52 PM    More...
Access Pharmaceuticals (ACCP) Signs US License Agreement With AMAG Pharmaceuticals, Inc. (AMAG) for MuGard 6/10/2013 10:27:20 AM    More...
Access Pharmaceuticals (ACCP) Reports First Quarter Results 5/16/2013 8:08:48 AM    More...
Access Pharmaceuticals (ACCP) to Host Fourth Quarter and Fiscal Year Investor Call on Wednesday, April 3rd at 11:00am ET 3/20/2013 7:49:23 AM    More...
12345678910...